Catyalyst Pharma (CPRX) Enters Agreement with FDA Under SPA for Firdapse Phase 3 Protocol Design, Endpoints, Analysis
Tweet Send to a Friend
Catalyst Pharmaceuticals, Inc. (Nasdaq: CPRX) announced that it has reached an agreement with the U.S. Food and Drug Administration (FDA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
